216 related articles for article (PubMed ID: 2450026)
21. Reduction in QT dispersion by sotalol following myocardial infarction.
Day CP; McComb JM; Matthews J; Campbell RW
Eur Heart J; 1991 Mar; 12(3):423-7. PubMed ID: 2040324
[TBL] [Abstract][Full Text] [Related]
22. [Post-extrasystolic long QT: evaluation and significance].
Haissaguerre M; Lemetayer P; Montserrat P; Massiere JP; Warin JF
Ann Cardiol Angeiol (Paris); 1991 Jan; 40(1):15-22. PubMed ID: 1708957
[TBL] [Abstract][Full Text] [Related]
23. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
[TBL] [Abstract][Full Text] [Related]
25. Role of QT interval at onset of acute myocardial infarction in predicting early phase ventricular arrhythmia.
Goswami KC; Nayak KC; Chadda VS
J Assoc Physicians India; 1992 May; 40(5):306-7. PubMed ID: 1282916
[TBL] [Abstract][Full Text] [Related]
26. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
[TBL] [Abstract][Full Text] [Related]
28. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
Day CP; McComb JM; Campbell RW
Br Heart J; 1990 Jun; 63(6):342-4. PubMed ID: 2375895
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity.
Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J
Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514
[TBL] [Abstract][Full Text] [Related]
30. Sotalol and a broken heart.
Friedman PL; Montgomery S; Matas N
J Cardiovasc Electrophysiol; 2010 Feb; 21(2):207-10. PubMed ID: 19563362
[TBL] [Abstract][Full Text] [Related]
31. [Incidence of ventricular arrhythmia relative to the QT interval in spontaneous intracranial hemorrhages].
Sen S; Stober T; Burger L; Anstätt T; Rettig G; Schieffer H
Dtsch Med Wochenschr; 1984 May; 109(21):817-20. PubMed ID: 6723536
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of sotalol in idiopathic ventricular arrhythmia originating in the right ventricular outflow tract].
Maia IG; Seixas TN; Costa AM; Peres AK; Magalhães Júnior A; Sá R; Alves PA
Arq Bras Cardiol; 1994 Jul; 63(1):59-63. PubMed ID: 7857216
[TBL] [Abstract][Full Text] [Related]
33. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
Somberg JC; Preston RA; Ranade V; Molnar J
Cardiology; 2010; 116(3):219-25. PubMed ID: 20693799
[TBL] [Abstract][Full Text] [Related]
34. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Cui G; Sen L; Sager P; Uppal P; Singh BN
Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiological effects of intravenous sotalol in acute myocardial infarction: a double-blind placebo-controlled study.
Aström M; Edhag O; Nyquist O; Vallin H
Eur Heart J; 1990 Jan; 11(1):35-42. PubMed ID: 2407533
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
Advani SV; Singh BN
Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of sotalol in suppressing ventricular ectopic beats.
Myburgh DP; Goldman aP; Cartoon J; Schamroth JM
S Afr Med J; 1979 Aug; 56(8):295-8. PubMed ID: 399099
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
[TBL] [Abstract][Full Text] [Related]
39. Beta-blockade by sotalol in early myocardial infarction decreases ventricular arrhythmias without increasing left ventricular volume.
Lloyd EA; Charles RG; Gordon GD; Adams CM; Mabin TA; Commerford PJ; Opie LH
S Afr Med J; 1988 Jul; 74(1):5-10. PubMed ID: 3291150
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.
Hohnloser SH; Zabel M; van de Loo A; Klingenheben T; Just H
Int J Cardiol; 1992 Dec; 37(3):283-91. PubMed ID: 1281807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
